Wohlwend J, Nathan A, Shalon N, Crain C, Tano-Menka R, Goldberg B
Nat Mach Intell. 2025; 7(2):232-243.
PMID: 40008296
PMC: 11847706.
DOI: 10.1038/s42256-024-00971-y.
Mai K, Pan W, Lin Z, Wang Y, Yang Z
Adv Biotechnol (Singap). 2025; 3(1):5.
PMID: 39883362
DOI: 10.1007/s44307-025-00057-9.
Zhang J, Yang Y, Wang B, Qiu W, Zhang H, Qiu Y
Front Immunol. 2024; 15:1427677.
PMID: 39703502
PMC: 11655343.
DOI: 10.3389/fimmu.2024.1427677.
Moin A, Rani N, Sharker Y, Ahammed T, Rahman U, Yasmin S
Sci Rep. 2024; 14(1):27020.
PMID: 39505874
PMC: 11542017.
DOI: 10.1038/s41598-024-72116-5.
Kaur A, Kumar A, Kumari G, Muduli R, Das M, Kundu R
Heliyon. 2024; 10(16):e36154.
PMID: 39247273
PMC: 11380015.
DOI: 10.1016/j.heliyon.2024.e36154.
Serological Conversion through a Second Exposure to Inactivated Foot-and-Mouth Disease Virus Expressing the JC Epitope on the Viral Surface.
Hwang S, Shin S, Park S, Lee M, Kim S, Lee J
Vaccines (Basel). 2023; 11(9).
PMID: 37766163
PMC: 10537882.
DOI: 10.3390/vaccines11091487.
Epitopes and Mimotopes Identification Using Phage Display for Vaccine Development against Infectious Pathogens.
Palma M
Vaccines (Basel). 2023; 11(7).
PMID: 37514992
PMC: 10384025.
DOI: 10.3390/vaccines11071176.
disease associates with higher HIV-1-specific antibody responses.
Adeoye B, Nakiyingi L, Moreau Y, Nankya E, Olson A, Zhang M
iScience. 2023; 26(5):106631.
PMID: 37168567
PMC: 10165194.
DOI: 10.1016/j.isci.2023.106631.
Molecular Mimicry of SARS-CoV-2 Spike Protein in the Nervous System: A Bioinformatics Approach.
Cuspoca A, Isaac Estrada P, Velez-Van-Meerbeke A
Comput Struct Biotechnol J. 2022; 20:6041-6054.
PMID: 36317085
PMC: 9605789.
DOI: 10.1016/j.csbj.2022.10.022.
Reaction of SARS-CoV-2 antibodies with other pathogens, vaccines, and food antigens.
Vojdani A, Vojdani E, Melgar A, Redd J
Front Immunol. 2022; 13:1003094.
PMID: 36211404
PMC: 9537454.
DOI: 10.3389/fimmu.2022.1003094.
Measles, mumps and rubella vaccine and heterologous immunity: a way out of the COVID-19 crisis?.
Shrivastava J, Narang M, Gomber S
Sudan J Paediatr. 2022; 22(1):10-18.
PMID: 35958081
PMC: 9361497.
DOI: 10.24911/SJP.106-1621869672.
Heterologous Immune Responses of Serum IgG and Secretory IgA Against the Spike Protein of Endemic Coronaviruses During Severe COVID-19.
Smit W, van Tol S, van der Wal S, van Vulpen F, la Grouw S, van Lelyveld L
Front Immunol. 2022; 13:839367.
PMID: 35355988
PMC: 8959642.
DOI: 10.3389/fimmu.2022.839367.
Rapid Generation of Coronaviral Immunity Using Recombinant Peptide Modified Nanodiamonds.
Bilyy R, Pagneux Q, Francois N, Bila G, Grytsko R, Lebedin Y
Pathogens. 2021; 10(7).
PMID: 34358011
PMC: 8308543.
DOI: 10.3390/pathogens10070861.
Progress towards the development of a vaccine.
De S, Ntumngia F, Nicholas J, Adams J
Expert Rev Vaccines. 2021; 20(2):97-112.
PMID: 33481638
PMC: 7994195.
DOI: 10.1080/14760584.2021.1880898.
Predicting Cross-Reactivity and Antigen Specificity of T Cell Receptors.
Lee C, Salio M, Napolitani G, Ogg G, Simmons A, Koohy H
Front Immunol. 2020; 11:565096.
PMID: 33193332
PMC: 7642207.
DOI: 10.3389/fimmu.2020.565096.
Potential Cross-Reactive Immunity to SARS-CoV-2 From Common Human Pathogens and Vaccines.
Reche P
Front Immunol. 2020; 11:586984.
PMID: 33178220
PMC: 7596387.
DOI: 10.3389/fimmu.2020.586984.
Strong immunity against COVID-19 in the early two years of age links to frequent immunization of routine vaccines.
Qiu L, Zhang C, Wu J, Luo J, Netea M, Luo Z
Sci Bull (Beijing). 2020; 65(24):2057-2060.
PMID: 32837766
PMC: 7414308.
DOI: 10.1016/j.scib.2020.08.012.
Heterologous Immunity between Adenoviruses and Hepatitis C Virus (HCV): Recombinant Adenovirus Vaccine Vectors Containing Antigens from Unrelated Pathogens Induce Cross-Reactive Immunity Against HCV Antigens.
Agrawal B, Gupta N, Vedi S, Singh S, Li W, Garg S
Cells. 2019; 8(5).
PMID: 31130710
PMC: 6562520.
DOI: 10.3390/cells8050507.
The Role of Pre-existing Cross-Reactive Central Memory CD4 T-Cells in Vaccination With Previously Unseen Influenza Strains.
Nienen M, Stervbo U, Molder F, Kaliszczyk S, Kuchenbecker L, Gayova L
Front Immunol. 2019; 10:593.
PMID: 31019503
PMC: 6458262.
DOI: 10.3389/fimmu.2019.00593.
Novel Protein-Based Pneumococcal Vaccines: Assessing the Use of Distinct Protein Fragments Instead of Full-Length Proteins as Vaccine Antigens.
Lagousi T, Basdeki P, Routsias J, Spoulou V
Vaccines (Basel). 2019; 7(1).
PMID: 30669439
PMC: 6466302.
DOI: 10.3390/vaccines7010009.